Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/14/2025

Parathyroid Dysfunction in Anxiety Disorders

Introduction to Parathyroid Dysfunction

  • Significant comorbidity exists between anxiety disorders and thyroid disorders, with nearly all studies finding this association significant, according to the American Psychiatric Association 1
  • Hyperthyroidism frequently produces anxiety symptoms including nervousness, palpitations, and increased perspiration that overlap with panic disorder, as noted by the National Institute of Mental Health 1
  • Patients with generalized anxiety disorder show 10.4% prevalence of thyroid disorders, higher than the general population, as reported by the Anxiety and Depression Association of America 4
  • Subclinical thyroid dysfunction demonstrates a negative association between TSH levels and self-reported anxiety in large population samples, according to the Endocrine Society 6

Parathyroid Dysfunction Screening

  • Anxiety symptoms can be a manifestation of parathyroid dysfunction, and screening for parathyroid function is recommended in patients with treatment-resistant anxiety or atypical symptom clusters, as suggested by the American College of Endocrinology 6
  • The initial screening should include serum calcium concentration, serum phosphate, and serum magnesium levels, as recommended by the National Academy of Clinical Biochemistry 8

Diagnostic Approach

  • If divalent cation abnormalities are confirmed, measure parathyroid hormone (PTH) levels and assess for end-organ complications, as recommended by the American Association of Clinical Endocrinologists 8
  • Psychiatric evaluations should include serum calcium concentration testing, which is essential in reassessing patients poorly responsive to mental illness treatment, according to the American Psychiatric Association 8

Quality of Life Implications

  • The impact on morbidity and quality of life is substantial, with hypoparathyroid patients on standard treatment showing significantly impaired well-being with predominant anxiety and phobic anxiety symptoms, as reported by the National Institute of Mental Health 8
  • Failure to recognize parathyroid disorders leaves endocrine-induced mental dysfunction without proper treatment, perpetuating unnecessary suffering, as noted by the Endocrine Society 8